Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Adductor Canal Block in TKA
NCT02863120Phase 4Completed
- Sponsor
- Texas Orthopedics, Sports & Rehabilitation Associates
- Start
- Jul 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in knee osteoarthritis (OA), sponsored by Texas Orthopedics, Sports & Rehabilitation Associates. Started Jul 2016; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02863120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02863120.